ClinicalTrials.Veeva

Menu

Prognosis and Survival Estimates in Palliative Therapy

H

Heinrich-Heine University, Duesseldorf

Status

Completed

Conditions

Cancer

Treatments

Other: no specific interventions

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The accuracy of clinical survival estimates is tested in comparison to objective prognostic scores.

Full description

  • At presentation a clinical survival estimate is obtained in each patient.
  • Survival is also estimated using published prognostic scores in palliative care.
  • Prognostic scores based on blood samples, general symptoms, complaints, and performance status are calculated and validated, respectively
  • Each patient completes questionnaires on psychological distress
  • Survival estimates are limited to 6 months.
  • Each patient is followed for at least 6 months.

Enrollment

612 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • oncologic disease confirmed
  • incurable locally advanced or metastatic disease
  • palliative treatment intended
  • age > 18
  • able to understand the study protocol
  • able to complete the forms with assistance if necessary

Exclusion criteria

  • therapy with curative intent
  • regular clinical follow-up visit without disease progression
  • ongoing therapy

Trial design

612 participants in 1 patient group

Palliative Therapy
Description:
Patients referred to the oncology / radiation oncology departments for palliative therapy.
Treatment:
Other: no specific interventions

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems